Fee Bid In Vax Biz Suit 'Makes No Sense,' Chancery Told
Ashby & Geddes PA and Levi & Korsinsky LLP are being blasted for seeking $1.5 million for representing an investor in biotech company Novavax Inc. in a derivative suit filed in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article